ECSP20017939A - PHARMACEUTICAL COMPOSITIONS - Google Patents

PHARMACEUTICAL COMPOSITIONS

Info

Publication number
ECSP20017939A
ECSP20017939A ECSENADI202017939A ECDI202017939A ECSP20017939A EC SP20017939 A ECSP20017939 A EC SP20017939A EC SENADI202017939 A ECSENADI202017939 A EC SENADI202017939A EC DI202017939 A ECDI202017939 A EC DI202017939A EC SP20017939 A ECSP20017939 A EC SP20017939A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
attached
Prior art date
Application number
ECSENADI202017939A
Other languages
Spanish (es)
Inventor
Stephen John Pethen
Christopher Martyn Yea
Michael Bryan Roe
Gary Cook
Sally Marsh
Original Assignee
Kalvista Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1713660.7A external-priority patent/GB201713660D0/en
Application filed by Kalvista Pharmaceuticals Ltd filed Critical Kalvista Pharmaceuticals Ltd
Publication of ECSP20017939A publication Critical patent/ECSP20017939A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se adjunta resumenSummary is attached

ECSENADI202017939A 2017-08-11 2020-03-11 PHARMACEUTICAL COMPOSITIONS ECSP20017939A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762544346P 2017-08-11 2017-08-11
GBGB1713660.7A GB201713660D0 (en) 2017-08-25 2017-08-25 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ECSP20017939A true ECSP20017939A (en) 2020-04-22

Family

ID=70976595

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202017939A ECSP20017939A (en) 2017-08-11 2020-03-11 PHARMACEUTICAL COMPOSITIONS

Country Status (8)

Country Link
CL (1) CL2020000356A1 (en)
CO (1) CO2020002287A2 (en)
EC (1) ECSP20017939A (en)
IL (1) IL272428A (en)
MX (1) MX2020001356A (en)
PH (1) PH12020500246A1 (en)
RU (1) RU2020109955A (en)
UA (1) UA125537C2 (en)

Also Published As

Publication number Publication date
MX2020001356A (en) 2020-03-20
RU2020109955A3 (en) 2022-01-24
PH12020500246A1 (en) 2021-03-15
CO2020002287A2 (en) 2020-06-09
IL272428A (en) 2020-03-31
UA125537C2 (en) 2022-04-13
CL2020000356A1 (en) 2020-06-19
RU2020109955A (en) 2021-09-14

Similar Documents

Publication Publication Date Title
ECSP17029371A (en) ROR-GAMMA INHIBITING DIHYDROPYRROLOPYRIDINES
CL2019000992A1 (en) Pyrrolobenzodiazepine Conjugates.
CO2017002532A2 (en) Benzyl substituted indazoles as bub1 inhibitors
PL3510033T3 (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF TOLL-LIKE ENDOSOMAL RECEPTORS
PL4393545T3 (en) NEW APPLICATIONS OF PIPERIDINYL-INDOLE DERIVATIVES
EP3509581A4 (en) FORMULATIONS OF (R
TWD174683S (en) Ring
UY36498A (en) PICOLINAMIDS AS FUNGICIDES
EP3606559C0 (en) BIO-ORTHOGONAL COMPOSITIONS
ECSP17015977A (en) COMBINATION THERAPY
PT3645518T (en) SUMMARY OF OMECAMTIV MECARBIL
EP3364944C0 (en) PHARMACEUTICAL COMPOSITIONS OF IL-2
EP3688069A4 (en) SILICONE COMPOSITIONS
EP3860585A4 (en) THERAPEUTIC COMPOSITIONS
MX2018007390A (en) Compositions comprising 15-hepe and methods of using the same.
LT3651736T (en) LONG - TERM COMPOSITIONS
EP3674359A4 (en) COMPOSITION OF LATEX
ECSP18018793A (en) HELPFUL COMPOUNDS TO INHIBIT ROR-GAMMA-T
DK4234656T3 (en) COMPOSITIONS
MX2017000862A (en) FACTOR FORMULATION VIII.
DK3678644T3 (en) FORMULATIONS OF COPANLISIB
EP3894418A4 (en) PREPARATION OF TRIIODOSILANE
IL285765A (en) Medicinal uses of dolaglutide
PT3765379T (en) COMPOSITIONS
MX373197B (en) STABLE FORMULATIONS OF TESTOSTERONE UNDECANOATE.